Wellumio

Wellumio has completed an oversubscribed $9.75 million pre-Series A funding round to advance the clinical development, regulatory approval and commercialization of Axana, its portable brain imaging system for point-of-care stroke detection. The final clos

Wellumio closes $9.75M in pre-Series A funding to scale its 50kg, battery-powered Axana portable brain imaging device for point-of-care stroke diagnosis.

We examine Siemens Healthineers' web of eight-plus alliances - most notably its neurovascular robotics partnership with Stryker - and what it means for the acute stroke market. Our conclusion: competition in acute care is shifting from individual devices

And why point-of-care diagnostics may be the fastest way to change it Mechanical thrombectomy is no longer an emerging therapy. It is one of the clearest advances in acute stroke care over the past decade, supported by strong clinical evidence, stable rei

Wellumio raises $7.28M to advance Axana, a portable 50kg MRI device designed to diagnose strokes within the "golden hour" at the patient

WERNEUCHEN, GERMANY & MELBOURNE, AUSTRALIA MEYTEC, a leader in telemedicine and mobile emergency care technologies, and Wellumio, an...